Search research articles
Contact Us
Filters
Showing results (101-110 of 107) with videos related to
Page
of 11
Sort By:
You have reached the last page of results.
This site can display upto 107 results.
The Journal of Investigative Dermatology
|
September 29, 2022
Hypoxia Controls the Glycome Signature and Galectin-8-Ligand Axis to Promote Protumorigenic Properties of Metastatic Melanoma
Asmi Chakraborty, Mariana Perez, Jordan D Carroll, et al.
The FEBS Journal
|
March 22, 2021
Emerging glyco-based strategies to steer immune responses
Marko Anderluh, Francesco Berti, Anna Bzducha-Wróbel, et al.
The FEBS Journal
|
May 2, 2021
Recent advances on smart glycoconjugate vaccines in infections and cancer
Marko Anderluh, Francesco Berti, Anna Bzducha-Wróbel, et al.
The Journal of Clinical Investigation
|
February 2, 2016
Training the next generation of biomedical investigators in glycosciences
Peter Agre, Carolyn Bertozzi, Mina Bissell, et al.
Frontiers in Immunology
|
September 28, 2020
Corrigendum: Cost-Effective, Safe, and Personalized Cell Therapy for Critical Limb Ischemia in Type 2 Diabetes Mellitus
Bárbara Soria-Juan, Natalia Escacena, Vivian Capilla-González, et al.
Frontiers in Immunology
|
June 25, 2019
Cost-Effective, Safe, and Personalized Cell Therapy for Critical Limb Ischemia in Type 2 Diabetes Mellitus
Bárbara Soria-Juan, Natalia Escacena, Vivian Capilla-González, et al.
Cytotherapy
|
December 15, 2025
Ex vivo mesenchymal progenitor cell-based cord blood cell expansion and exofucosylation to enhance transplant engraftment
Portia Smallbone, Mayela Mendt, Robert Sackstein, et al.
Page
of 11
Search research articles
Search
Showing results (101-110 of 107) with videos related to
Sort By:
Page
of 11
You have reached the last page of results.
This site can display upto 107 results.
The Journal of Investigative Dermatology
|
September 29, 2022
Hypoxia Controls the Glycome Signature and Galectin-8-Ligand Axis to Promote Protumorigenic Properties of Metastatic Melanoma
Asmi Chakraborty, Mariana Perez, Jordan D Carroll, et al.
The FEBS Journal
|
March 22, 2021
Emerging glyco-based strategies to steer immune responses
Marko Anderluh, Francesco Berti, Anna Bzducha-Wróbel, et al.
The FEBS Journal
|
May 2, 2021
Recent advances on smart glycoconjugate vaccines in infections and cancer
Marko Anderluh, Francesco Berti, Anna Bzducha-Wróbel, et al.
The Journal of Clinical Investigation
|
February 2, 2016
Training the next generation of biomedical investigators in glycosciences
Peter Agre, Carolyn Bertozzi, Mina Bissell, et al.
Frontiers in Immunology
|
September 28, 2020
Corrigendum: Cost-Effective, Safe, and Personalized Cell Therapy for Critical Limb Ischemia in Type 2 Diabetes Mellitus
Bárbara Soria-Juan, Natalia Escacena, Vivian Capilla-González, et al.
Frontiers in Immunology
|
June 25, 2019
Cost-Effective, Safe, and Personalized Cell Therapy for Critical Limb Ischemia in Type 2 Diabetes Mellitus
Bárbara Soria-Juan, Natalia Escacena, Vivian Capilla-González, et al.
Cytotherapy
|
December 15, 2025
Ex vivo mesenchymal progenitor cell-based cord blood cell expansion and exofucosylation to enhance transplant engraftment
Portia Smallbone, Mayela Mendt, Robert Sackstein, et al.
Page
of 11